Is Intelligent Bio Solutions Inc. (INBS) overvalued? · rev $4.2M
Intelligent Bio Solutions Inc. (INBS) is a medical devices company listed on US.
This page asks whether Intelligent Bio Solutions Inc. (INBS) looks expensive on cached numbers — not a short thesis.
Latest reported INBS revenue for 2026-06-30 was $4.2M. Net income was -$12.4M. Revenue was up 38.1% from 2025-06-30 to 2026-06-30. INBS currently screens at market cap $5.9M.
INBS currently screens at market cap $5.9M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next INBS 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the INBS stock page for the full model, not this heading.
Not investment advice.